Question 1

What is the catalog number for STN 486-200X250-B7527 Prohibited Activity Signs (No Adhesive)?

Accepted Answer

The catalog number for STN 486-200X250-B7527 Prohibited Activity Signs (No Adhesive) is 223915.

Question 2

What sizes are available for STN 486-200X250-B7527 Prohibited Activity Signs (No Adhesive)?

Accepted Answer

STN 486-200X250-B7527 Prohibited Activity Signs (No Adhesive) is available in the following size(s): 1 Card (1 Panel (s) x 1 Pack).

Question 3

Is STN 486-200X250-B7527 Prohibited Activity Signs (No Adhesive) in stock?

Accepted Answer

STN 486-200X250-B7527 Prohibited Activity Signs (No Adhesive) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is STN 486-200X250-B7527 Prohibited Activity Signs (No Adhesive) used for?

Accepted Answer

Pictogram - Prohibition - EXTINGUISH YOUR CIGARETTE HERE

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 7

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

STN 486-200X250-B7527 Prohibited Activity Signs (No Adhesive)

Product Specifications

MOQ

UNSPSC

Weight

Shipping Width

Shipping Height

Width

Height

Depth

Frequently Asked Questions

Explore Other Products

Anti-Bcl-XS/BCL2L1 Antibody Picoband®, Dylight594 Conjugate

Ferritin, Light Chain (FTL) (Microglia Marker) (FTL/1389), CF594 conjugate, 0.1mg/mL

Cycloxygenase-2 (COX-2) (COX2/1941), 1mg/mL

Anti-MHC class 1 HLA-A Rabbit Monoclonal Antibody

ICOS-L / ICOS Ligand / B7RP-1 (Immuno-Oncology Target) (ICOSL/3260), CF740 conjugate, 0.1mg/mL

HSP60 (LK1), CF594 conjugate, 0.1mg/mL